130 related articles for article (PubMed ID: 31760095)
1. Evaluation of Polysaccharide Typhim Vi Antibody Response as a predictor of Humoral Immunodeficiency in Haematological Malignancies.
Ochoa-Grullón J; Benavente Cuesta C; Pérez López C; Peña Cortijo A; Rodríguez de la Peña A; Álvarez Carmona A; Mateo Morales M; Llano-Hernández K; Williams LJ; Rodríguez de Frías E; Guevara-Hoyer K; Cordero Torres G; Orte C; Fernández-Arquero M; Fernández-Paredes L; Serrano-García I; Recio MJ; Pérez de Diego R; Martínez R; Sánchez-Ramón S
Clin Immunol; 2020 Jan; 210():108307. PubMed ID: 31760095
[TBL] [Abstract][Full Text] [Related]
2. Measurement of Typhim Vi IgG as a Diagnostic Tool to Determine Anti-polysaccharide Antibody Production Deficiency in Children.
Guevara-Hoyer K; Gil C; Parker AR; Williams LJ; Orte C; Rodriguez de la Peña A; Ochoa-Grullón J; Rodriguez De Frias E; García IS; García-Gómez S; Recio MJ; Fernández-Arquero M; Pérez de Diego R; Ramos JT; Sánchez-Ramón S
Front Immunol; 2019; 10():654. PubMed ID: 31001267
[No Abstract] [Full Text] [Related]
3. Measurement of Typhi Vi antibodies can be used to assess adaptive immunity in patients with immunodeficiency.
Evans C; Bateman E; Steven R; Ponsford M; Cullinane A; Shenton C; Duthie G; Conlon C; Jolles S; Huissoon AP; Longhurst HJ; Rahman T; Scott C; Wallis G; Harding S; Parker AR; Ferry BL
Clin Exp Immunol; 2018 Jun; 192(3):292-301. PubMed ID: 29377063
[TBL] [Abstract][Full Text] [Related]
4. The Use of Salmonella Typhim Vaccine to Diagnose Antibody Deficiency.
Bausch-Jurken MT; Verbsky JW; Gonzaga KA; Elms NP; Hintermeyer MK; Gauld SB; Routes JM
J Clin Immunol; 2017 Jul; 37(5):427-433. PubMed ID: 28589420
[TBL] [Abstract][Full Text] [Related]
5. Multicenter study for the evaluation of the antibody response against salmonella typhi Vi vaccination (EMPATHY) for the diagnosis of Anti-polysaccharide antibody production deficiency in patients with primary immunodeficiency.
Sánchez-Ramón S; de Gracia J; García-Alonso AM; Rodríguez Molina JJ; Melero J; de Andrés A; García Ruiz de Morales JM; Ferreira A; Ocejo-Vinyals JG; Cid JJ; García Martínez JM; Lasheras T; Vargas ML; Gil-Herrera J; García Rodríguez MC; Castañer JL; González Granado LI; Allende LM; Soler-Palacin P; Herráiz L; López Hoyos M; Bellón JM; Silva G; Gurbindo DM; Carbone J; Rodríguez-Sáinz C; Matamoros N; Parker AR; Fernández-Cruz E;
Clin Immunol; 2016 Aug; 169():80-84. PubMed ID: 27236002
[No Abstract] [Full Text] [Related]
6. Measurement and interpretation of Salmonella typhi Vi IgG antibodies for the assessment of adaptive immunity.
Parker AR; Bradley C; Harding S; Sánchez-Ramón S; Jolles S; Kiani-Alikhan S
J Immunol Methods; 2018 Aug; 459():1-10. PubMed ID: 29800575
[TBL] [Abstract][Full Text] [Related]
7. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
[TBL] [Abstract][Full Text] [Related]
8. Defining Polysaccharide Antibody Deficiency: Measurement of Anti-Pneumococcal Antibodies and Anti-Salmonella typhi Antibodies in a Cohort of Patients with Recurrent Infections.
Bucciol G; Schaballie H; Schrijvers R; Bosch B; Proesmans M; De Boeck K; Boon M; Vermeulen F; Lorent N; Dillaerts D; Kantsø B; Jørgensen CS; Emonds MP; Bossuyt X; Moens L; Meyts I
J Clin Immunol; 2020 Jan; 40(1):105-113. PubMed ID: 31705452
[TBL] [Abstract][Full Text] [Related]
9. Impaired antibody response after immunization of HIV-infected individuals with the polysaccharide vaccine against Salmonella typhi (Typhim-Vi).
Kroon FP; van Dissel JT; Ravensbergen E; Nibbering PH; van Furth R
Vaccine; 1999 Aug; 17(23-24):2941-5. PubMed ID: 10462227
[TBL] [Abstract][Full Text] [Related]
10. A phase 1 randomized safety, reactogenicity, and immunogenicity study of Typhax: A novel protein capsular matrix vaccine candidate for the prevention of typhoid fever.
Cartee RT; Thanawastien A; Griffin Iv TJ; Mekalanos JJ; Bart S; Killeen KP
PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007912. PubMed ID: 31905228
[TBL] [Abstract][Full Text] [Related]
11. Vi Capsular Polysaccharide Produced by Recombinant
Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of a new Salmonella Typhi Vi polysaccharide vaccine--vax-TyVi--in Cuban school children and teenagers.
Azze RF; Rodríguez JC; Iniesta MG; Marchena XR; Alfonso VM; Padrón FT
Vaccine; 2003 Jun; 21(21-22):2758-60. PubMed ID: 12798615
[TBL] [Abstract][Full Text] [Related]
13. Typhim vi immunization assists to discriminate primary antibody responses in hematological malignancies.
Ochoa-Grullón J; Orte C; Rodríguez de la Peña A; Guevara-Hoyer K; Cordero Torres G; Fernández-Arquero M; Serrano-García I; Recio MJ; Pérez de Diego R; Sánchez-Ramón S
MethodsX; 2020; 7():100936. PubMed ID: 32551240
[TBL] [Abstract][Full Text] [Related]
14. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.
Pakkanen SH; Kantele JM; Herzog C; Kantele A
Vaccine; 2014 Jan; 32(5):544-51. PubMed ID: 24342246
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of anti Vi antibodies and immunogenicity of Typhim Vi vaccine in children.
Gupta D; Faridi MM; Aggarwal A; Kaur I
Hum Vaccin; 2008; 4(4):305-8. PubMed ID: 18398301
[TBL] [Abstract][Full Text] [Related]
16. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
[TBL] [Abstract][Full Text] [Related]
17. Duration of Vi antibodies in participants vaccinated with Typhim Vi (Typhoid Vi polysaccharide vaccine) in an area not endemic for typhoid fever.
Froeschle JE; Decker MD
Vaccine; 2010 Feb; 28(6):1451-3. PubMed ID: 20003920
[TBL] [Abstract][Full Text] [Related]
18. A Salmonella typhi Vi conjugate vaccine.
Koul PA
N Engl J Med; 2001 Aug; 345(7):545-6. PubMed ID: 11519517
[No Abstract] [Full Text] [Related]
19. Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children.
Mai NL; Phan VB; Vo AH; Tran CT; Lin FY; Bryla DA; Chu C; Schiloach J; Robbins JB; Schneerson R; Szu SC
N Engl J Med; 2003 Oct; 349(14):1390-1. PubMed ID: 14523155
[No Abstract] [Full Text] [Related]
20. An evaluation of purified Salmonella Typhi protein antigens for the serological diagnosis of acute typhoid fever.
Tran Vu Thieu N; Trinh Van T; Tran Tuan A; Klemm EJ; Nguyen Ngoc Minh C; Voong Vinh P; Pham Thanh D; Ho Ngoc Dan T; Pham Duc T; Langat P; Martin LB; Galan J; Liang L; Felgner PL; Davies DH; de Jong HK; Maude RR; Fukushima M; Wijedoru L; Ghose A; Samad R; Dondorp AM; Faiz A; Darton TC; Pollard AJ; Thwaites GE; Dougan G; Parry CM; Baker S
J Infect; 2017 Aug; 75(2):104-114. PubMed ID: 28551371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
